# ARS Pharmaceuticals, Inc.: Form 8-K, filed Jun 25, 2026

- Company: [ARS Pharmaceuticals, Inc.](/companies/spry.md) (CIK 1671858)
- Form: 8-K
- Filed: 2026-06-25
- Accepted by EDGAR: Jun 25, 2026, 17:01 ET
- Period: 2026-06-24
- Accession: 0001193125-26-282994
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1671858/000119312526282994/d26870d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1671858/000119312526282994/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1671858/000119312526282994/d26870d8k.htm

Filed Jun 25, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-282994. Last ingested by Listed: Oct 30, 2026, 16:39 ET. No prices; not investment advice.